1¿ù 18ÀÏ Åä¿äÀÏ
¾ÆÀ̵ð
ºñ¹Ð¹øÈ£
¾ÆÀ̵ð ã±â
Ƽ¼ÅÃ÷ (¹ÝÆÈ)
Ƽ¼ÅÃ÷ (±äÆÈ)
Ä¿Ç÷è (ÇÒÀÎ)
Á¡ÆÛ(ÆǸŸ¶°¨)
Ư°¡ÆǸŠ<==ÁøÇàÁß
ºþ¦¼¼ÀÏ
-Ä«µå°áÁ¦¿ë-
Home
> ¹®ÀÇ °Ô½ÃÆÇ ¼öÁ¤
°³ÀÎÁ¤º¸ À¯ÃâÀ» ¹æÁöÇϱâ À§ÇÏ¿© E-Mail°ú ÀüȹøÈ£´Â ÇØ´ç¶õ¿¡ ±âÀçÇÏ¿© ÁÖ½Ã¸é °¨»çÇÏ°Ú½À´Ï´Ù.
À̸§
*
*
´Â ¹Ýµå½Ã ÀÔ·ÂÇØ ÁֽʽÿÀ.
Æнº¿öµå
*
¼öÁ¤, »èÁ¦½Ã¿¡ ÇÊ¿äÇÕ´Ï´Ù.
E-Mail
*
°ø°³ÇÏÁö ¾Ê½À´Ï´Ù.
ÀüȹøÈ£
°ø°³ÇÏÁö ¾Ê½À´Ï´Ù.
Á¦¸ñ
*
³»¿ë
*
What sort of work do you do?
where can i buy ivermectin for guinea pigs
Activist investor ValueAct Capital, which had built up an 8percent-plus stake in Invensys over recent months, sold 4million shares on Friday at 508.19 pence, trimming its holdingto 7.52 percent, according to regulatory filings, and suggestingperhaps that it is cautious about the prospect of a bid battle.
¸ñ·Ï
»ç¾÷ÀÚµî·Ï¹øÈ£: 607-10-79364 ºÎ°¡Åë½Å»ç¾÷½Å°í : ºÎ»ê Á¦ 455È£
Copyright (C) 2001 Å©¸®¿¡ÀÌƼºê µðÁöÅÐ All rights reserved.